王洁，1965年生，中国医科院肿瘤医院内科主任，主任医师，亚洲通网址,亚洲通：长聘教授。中国临床肿瘤学会副理事长，中国医师协会肿瘤多学科专委会主任委员。近30年来致力于肺癌分子分型基础上精准诊治及转化研究工作。主持国自然基金重点项目、科技部专项等20余项。国家自然科学基金委杰出青年基金获得者，以第一完成人获得国家科技进步二等奖，获全国创新争先奖、何梁何利基金科学技术与进步奖、吴阶平医药创新奖、中国青年女科学家奖、教育部创新团队带头人等。

肺癌、胸膜间皮瘤、胸腺肿瘤的精准诊治；肺癌分子分型、免疫分型的转化和临床研究。

亚洲通网址,亚洲通

1. Jie Wang#, Caicun Zhou, Wenxiu Yao, Qiming Wang, Xuhong Min, Gongyan Chen, Xingxiang Xu, Xingya Li, Fei Xu, Yong Fang, Runxiang Yang, Guohua Yu, Youling Gong, Jun Zhao, Yun Fan, Quan Liu, Lejie Cao, Yu Yao, Yunpeng Liu, Xiaoling Li, Jingxun Wu, Zhiyong He, Kaihua Lu, Liyan Jiang, Chengping Hu, Wenhua Zhao, Ben Zhang, Wei Shi, Xiaojing Zhang, Ying Cheng. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022 Jun;23(6): 739-747. (IF=54.4)

2. Jiachen Xu, Zheng Liu, Hua Bai, Guilan Dong, Jia Zhong, Rui Wan, Aiming Zang, Xiaoling Li, Qingshan Li, Jun Guo, Nan Du, Diansheng Zhong, Yan Huang, Qun Lv, Jinghua Zhang, Yue Zhao, Liming Gao, Lin Li, Chunyi Zhang, Jun Zhao, Baolan Li, Zhe Liu, Zhenlin Yang, Dong Ji, Tao Wang, Jianchun Duan, Zhijie Wang, Jie Wang*. Evaluation of Clinical Outcomes of Icotinib in Patients With Clinically Diagnosed Advanced Lung Cancer With EGFR-Sensitizing Variants Assessed by Circul